Enhanced tumor suppression in vitro and in vivo by co-expression of survivin-specific siRNA and wild-type p53 protein
Authors:
Open Access
- 13 August 2010
- journal article
- research article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 17 (12) , 844-854
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- p53 Immunostaining guided laser capture microdissection (p53-LCM) defines the presence of p53 gene mutations in focal regions of primary prostate cancer positive for p53 proteinProstate Cancer and Prostatic Diseases, 2003
- Exploring the Functional Interactions between Aurora B, INCENP, and Survivin in MitosisMolecular Biology of the Cell, 2003
- Downregulation of KAI1 mRNA in localised prostate cancer and its bony metastases does not correlate with p53 overexpressionProstate Cancer and Prostatic Diseases, 2003
- Prognostic importance of survivin in breast cancerBritish Journal of Cancer, 2003
- Characterization of Monoclonal Antibodies Against GRIM-19, a Novel IFN- β and Retinoic Acid-Activated Regulator of Cell DeathJournal of Interferon & Cytokine Research, 2002
- c-MYC: more than just a matter of life and deathNature Reviews Cancer, 2002
- Aurora B Kinase Exists in a Complex with Survivin and INCENP and Its Kinase Activity Is Stimulated by Survivin Binding and PhosphorylationMolecular Biology of the Cell, 2002
- Expression of survivin in primary glioblastomasJournal of Cancer Research and Clinical Oncology, 2002
- Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinomaBritish Journal of Cancer, 2002
- Transcriptional Repression of the Anti-apoptoticsurvivin Gene by Wild Type p53Journal of Biological Chemistry, 2002